Highlights Sanofi BOERSE MUENCHEN

Equities

SNW

FR0000120578

Real-time BOERSE MUENCHEN Other stock markets 09:47:16 02/07/2024 pm IST			5-day change	1st Jan Change
90.64 ^EUR	-1.62%		+1.24%	+2.61%

06:12pm	Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	MT
01:36pm	SANOFI : Jefferies reaffirms its Buy rating	ZD

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	09:42pm	MT
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	03:54pm	MT
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge	04:07am	RE
Sanofi could invest up to EUR1.5 bn in its German insulin production site-source	01/07	RE
Sanofi eyes German insulin investment of up to $1.6 bln, source says	01/07	RE
Sector Update: Health Care Stocks Mixed Premarket Monday	01/07	MT
'HB': Sanofi plans to invest billions in Frankfurt	01/07	DP
Sanofi Eyes Up to $1.61 Billion Investment at German Production Site	01/07	MT
Sanofi Mulls Up to EUR1.5 Billion Investment in Germany	01/07	MT
Sanofi eyes investment of up to $1.6 billion in Germany, Handelsblatt says	01/07	RE
CAC40: caution prevails ahead of crucial deadlines	27/06	CF
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	27/06	MT
Top Premarket Gainers	27/06	MT
Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment	27/06	DJ
Regeneron, Sanofi Eosinophilic Esophagitis Treatment Showed Improvements for Children in Phase 3 Study	27/06	MT
Vigil Neuroscience Receives $40 Million Investment From Sanofi	27/06	MT
Sanofi: positive publication for Dupixent in NEJM	27/06	CF
Sanofi Partakes in Formation Bio's $372 Million Fundraising	27/06	MT
Regeneron Pharmaceuticals, Inc Announces Dupixent® Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	27/06	CI
FDA approves Verona Pharma's therapy for 'smoker's lungs'	27/06	RE